Pharmacokinetics and the transition to extended half‐life factor concentrates: communication from the SSC of the ISTH von Ragni, M. V., Croteau, S. E., Morfini, M., Cnossen, M. H., Iorio, A.

Volltext

Age dependency of coagulation parameters during childhood and puberty von APPEL, I. M., GRIMMINCK, B., GEERTS, J., STIGTER, R., CNOSSEN, M. H., BEISHUIZEN, A.

Volltext

Setting the stage for individualized therapy in hemophilia: What role can pharmacokinetics play? von Hazendonk, H.C.A.M., van Moort, I., Mathôt, R.A.A., Fijnvandraat, K., Leebeek, F.W.G., Collins, P.W., Cnossen, M.H.

Volltext

Reduced prevalence of arterial thrombosis in von Willebrand disease von Sanders, Y. V., Eikenboom, J., Wee, E. M., Bom, J. G., Cnossen, M. H., Degenaar‐Dujardin, M. E. L., Fijnvandraat, K., Kamphuisen, P. W., Laros‐van Gorkom, B. A. P., Meijer, K., Mauser‐Bunschoten, E. P., Leebeek, F. W. G.

Volltext

Cross-evaluation of Pharmacokinetic-Guided Dosing Tools for Factor VIII von Preijers, T., van Moort, I., Fijnvandraat, K., Leebeek, F. W. G., Cnossen, M. H., Mathôt, R. A. A.

Volltext

Clinically relevant differences between assays for von Willebrand factor activity von Boender, J., Eikenboom, J., Bom, J. G., Meijer, K., Meris, J., Fijnvandraat, K., Cnossen, M. H., Laros‐van Gorkom, B. A. P., Heerde, W. L., Mauser‐Bunschoten, E. P., Maat, M. P. M., Leebeek, F. W. G.

Volltext

Sickle cell disease: Clinical presentation and management of a global health challenge von Houwing, M.E., de Pagter, P.J., van Beers, E.J., Biemond, B.J., Rettenbacher, E., Rijneveld, A.W., Schols, E.M., Philipsen, J.N.J., Tamminga, R.Y.J., van Draat, K. Fijn, Nur, E., Cnossen, M.H.

Volltext

von Willebrand disease and aging: an evolving phenotype von Sanders, Y. V., Giezenaar, M. A., Laros‐van Gorkom, B. A. P., Meijer, K., Bom, J. G., Cnossen, M. H., Nijziel, M. R., Ypma, P. F., Fijnvandraat, K., Eikenboom, J., Mauser‐Bunschoten, E. P., Leebeek, F. W. G.

Volltext

Major differences in clinical presentation, diagnosis and management of men and women with autosomal inherited bleeding disorders von Atiq, F., Saes, J.L., Punt, M.C., van Galen, K.P.M., Schutgens, R.E.G., Meijer, K., Cnossen, M.H., Laros-Van Gorkom, B.A.P., Peters, M., Nieuwenhuizen, L., Kruip, M.J.H.A., de Meris, J., van der Bom, J.G., van der Meer, F.J.M., Fijnvandraat, K., Kruis, I.C., van Heerde, W.L., Eikenboom, H.C.J., Leebeek, Frank W.G., Schols, S.E.M.

Volltext

In Vivo T1 of Blood Measurements in Children with Sickle Cell Disease Improve Cerebral Blood Flow Quantification from Arterial Spin-Labeling MRI von Václavů, L, van der Land, V, Heijtel, D F R, van Osch, M J P, Cnossen, M H, Majoie, C B L M, Bush, A, Wood, J C, Fijnvandraat, K J, Mutsaerts, H J M M, Nederveen, A J

Volltext

CLEC4M and STXBP5 gene variations contribute to von Willebrand factor level variation in von Willebrand disease von Sanders, Y. V., Bom, J. G., Isaacs, A., Cnossen, M. H., Maat, M. P. M., Laros‐van Gorkom, B. A. P., Fijnvandraat, K., Meijer, K., Duijn, C. M., Mauser‐Bunschoten, E. P., Eikenboom, J., Leebeek, F. W. G., Coppens, M., Kors, A., Meris, J., Nijziel, M. R., Tamminga, R. Y. J., Ypma, P. F., Smiers, F. J. W., Granzen, B., Hamulyák, K., Brons, P.

Volltext

Validation and reliability of the Abbreviated World Health Organization Quality of Life Instrument (WHOQOL-BREF) in the hospitalized trauma population von Kruithof, N., Haagsma, J.A., Karabatzakis, M., Cnossen, M.C., de Munter, L., van de Ree, C.L.P., de Jongh, M.A.C., Polinder, S.

Volltext

Side effects of desmopressin in patients with bleeding disorders von Stoof, S. C. M., Cnossen, M. H., de Maat, M. P. M., Leebeek, F. W. G., Kruip, M. J. H. A.

Volltext

In silico evaluation of limited blood sampling strategies for individualized recombinant factor IX prophylaxis in hemophilia B patients von Preijers, T., Hazendonk, H. C. A. M., Fijnvandraat, K., Leebeek, F. W. G., Cnossen, M. H., Mathôt, R. A. A.

Volltext

In silico evaluation of limited sampling strategies for individualized dosing of extended half-life factor IX concentrates in hemophilia B patients von Preijers, T., van Spengler, M. W. F., Meijer, K., Fijnvandraat, K., Fischer, K., Leebeek, F. W. G., Cnossen, M. H., Mathôt, R. A. A.

Volltext

Perioperative treatment of hemophilia A patients: blood group O patients are at risk of bleeding complications von Hazendonk, H. C. A. M., Lock, J., Mathôt, R. A. A., Meijer, K., Peters, M., Laros‐van Gorkom, B. A. P., Meer, F. J. M., Driessens, M. H. E., Leebeek, F. W. G., Fijnvandraat, K., Cnossen, M. H.

Volltext

Fifth Åland Island conference on von Willebrand disease von Berntorp, E., Ågren, A., Aledort, L., Blombäck, M., Cnossen, M. H., Croteau, S. E., Depka, M., Federici, A. B., Goodeve, A., Goudemand, J., Mannucci, P. M., Mourik, M., Önundarson, P. T., Rodeghiero, F., Szántó, T., Windyga, J.

Volltext

Population pharmacokinetics of factor IX in hemophilia B patients undergoing surgery von Preijers, T., Hazendonk, H. C. A. M., Liesner, R., Chowdary, P., Driessens, M. H. E., Hart, D., Keeling, D., Laros‐van Gorkom, B. A. P., Meer, F. J. M., Meijer, K., Fijnvandraat, K., Leebeek, F. W. G., Collins, P. W., Cnossen, M. H., Mathôt, R. A. A., Kruip, M. J. A. H., Polinder, S., Lock, J., Moort, I., Heijdra, J. M., Nederlof, A., Jager, N., Coppens, M., Peters, M., Tamminga, R. Y. J., Brons, P., Eikenboom, H. C. J., Schutgens, R. E. G., Fischer, K., Zwaan, C. M., Vliet, I.

Volltext

Analysis of current perioperative management with Haemate® P/Humate P® in von Willebrand disease: Identifying the need for personalized treatment von Hazendonk, H. C. A. M., Heijdra, J. M., de Jager, N. C. B., Veerman, H. C., Boender, J., van Moort, I., Mathôt, R. A. A., Meijer, K., Laros‐van Gorkom, B. A. P., Eikenboom, J., Fijnvandraat, K., Leebeek, F. W. G., Cnossen, M. H.

Volltext

Optimization of home treatment in haemophilia: effects of transmural support by a haemophilia nurse on adherence and quality of life von Lock, J., Raat, H., Peters, M., Scholten, M., Beijlevelt, M., Oostenbrink, R., Leebeek, F.W.G., Moll, H.A., Cnossen, M.H.

Volltext